SCHEMBL12577905

SCHEMBL12577905

Cc1ccc2nc3c4cccnc4c4ncccc4c3nc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NQO2 P16083 1/20 0.58
▸ ALDH1A1 P00352 4/20 0.53
▸ L3MBTL1 Q9Y468 4/20 0.50
▸ CCR1 P32246 4/20 0.50
▸ CCR8 P51685 4/20 0.50
▸ KDM4E B2RXH2 3/20 0.50
▸ NPC1 O15118 2/20 0.50
▸ HSP90AA1 P07900 1/20 0.50
▸ MEN1 O00255 1/20 0.46
▸ NR1I2 O75469 1/20 0.46
▸ AHR P35869 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ MAOA P21397 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ LMNA P02545 1/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ TP53 P04637 1/20 0.42
▸ PKM P14618 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12311063 0.85 NQO2 (0.67) NQO2ALDH1A1L3MBTL1KDM4EMEN1
SCHEMBL30022928 0.83 DHFR (0.53) ALDH1A1L3MBTL1CCR1CCR8KDM4E
SCHEMBL13286604 0.83 DHFR (0.53) ALDH1A1L3MBTL1CCR1CCR8KDM4E
SCHEMBL12553474 0.82 NPC1 (0.50) ALDH1A1L3MBTL1CCR1CCR8KDM4E
SCHEMBL30185055 0.81 L3MBTL1 (0.54) ALDH1A1L3MBTL1CCR1CCR8KDM4E
SCHEMBL166826 0.81 L3MBTL1 (0.54) ALDH1A1L3MBTL1CCR1CCR8KDM4E
SCHEMBL30185058 0.81 L3MBTL1 (0.54) ALDH1A1L3MBTL1CCR1CCR8KDM4E
SCHEMBL29390114 0.81 L3MBTL1 (0.54) ALDH1A1L3MBTL1CCR1CCR8KDM4E
SCHEMBL31036114 0.80 CCR1 (0.53) NQO2ALDH1A1L3MBTL1CCR1CCR8
SCHEMBL912017 0.80 CCR1 (0.53) NQO2ALDH1A1L3MBTL1CCR1CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11420990-B2 Ruthenium complex containing alkynyl group, method of synthesizing the same and use thereof GUANGDONG PHARMACEUTICAL UNIVERSITY (CN) 2022-08-23 — — US disclosed
US-20160039854-A1 METAL-BASED COORDINATION COMPLEXES AS PHOTODYNAMIC COMPOUNDS AND THEIR USE MCFARLAND SHERRI ANN (CA) 2016-02-11 — — US disclosed
US-8529796-B2 Charge transport compositions and electronic devices made with such compositions E I DU PONT DE NEMOURS AND COMPANY (US) 2013-09-10 — — US disclosed
US-20130009142-A1 CHARGE TRANSPORT COMPOSITIONS AND ELECTRONIC DEVICES MADE WITH SUCH COMPOSITIONS E I DU PONT DE NEMOURS AND COMPANY (US) 2013-01-10 — — US disclosed
US-8293139-B2 Charge transport compositions and electronic devices made with such compositions E I DU PONT DE NEMOURS AND COMPANY (US) 2012-10-23 — — US disclosed
US-8287769-B2 Charge transport compositions and electronic devices made with such compositions E I DU PONT DE NEMOURS AND COMPANY (US) 2012-10-16 — — US disclosed
US-20110140092-A1 CHARGE TRANSPORT COMPOSITIONS AND ELECTRONIC DEVICES MADE WITH SUCH COMPOSITIONS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-06-16 — — US disclosed
US-20110133173-A1 CHARGE TRANSPORT COMPOSITIONS AND ELECTRONIC DEVICES MADE WITH SUCH COMPOSITIONS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-06-09 — — US disclosed
US-7914706-B2 Quinoxaline derivative; light-emitting diode, light-emitting electrochemical cell, photodetector, anti-quenching materials E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-03-29 — — US disclosed
US-20090242837-A1 CHARGE TRANSPORT COMPOSITIONS AND ELECTRONIC DEVICES MADE WITH SUCH COMPOSITIONS E.I. DU PONT DE NEMOURS AND COMPANY (US) 2009-10-01 — — US disclosed
US-20080227981-A1 CHARGE TRANSPORT COMPOSITIONS AND ELECTRONIC DEVICES MADE WITH SUCH COMPOSITIONS LG CHEM, LTD. (KR) 2008-09-18 — — US disclosed
US-7399432-B2 Charge transport compositions and electronic devices made with such compositions E.I. DU PONT DE NEMOURS AND COMPANY (US) 2008-07-15 — — US disclosed
US-7265378-B2 Electronic devices made with electron transport and/or anti-quenching layers E. I. DU PONT DE NEMOURS AND COMPANY (US) 2007-09-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160039854-A1 METAL-BASED COORDINATION COMPLEXES AS PHOTODYNAMIC COMPOUNDS AND THEIR USE PIN1, PPIF, PPOX NQO2 4217/4885ALDH1A1 2483/4885L3MBTL1 2181/4885
US-11420990-B2 Ruthenium complex containing alkynyl group, method of synthesizing the same and use thereof HRH1, SLC7A5, SLC43A1 NQO2 3989/4885ALDH1A1 2214/4885L3MBTL1 657/4885
US-20080227981-A1 CHARGE TRANSPORT COMPOSITIONS AND ELECTRONIC DEVICES MADE WITH SUCH COMPOSITIONS SLC26A3, SLC6A19, SLC18A3 NQO2 2493/4885ALDH1A1 4036/4885L3MBTL1 3954/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback